Chelation of lysosomal iron protects against ionizing radiation

Biochemical Journal - Tập 432 Số 2 - Trang 295-301 - 2010
Carsten Berndt1,2, Tino Kurz3, Markus Selenius4, Aristi P. Fernandes4, Margareta Edgren5, Ulf T. Brunk3
1Division for Biochemistry, Department for Medical Biochemistry and Biophysics, Karolinska Institute, 171 77 Stockholm, Sweden
2Institute for Clinical Cytobiology and Cytopathology, Philipps-Universität, 35037 Marburg, Germany
3Division of Pharmacology, Faculty of Health Sciences, Linköping University, 581 85 Linköping, Sweden
4Division of Pathology, Department of Laboratory Medicine, Karolinska Institute, 141 86 Stockholm, Sweden
5Division of Medical Radiation Physics, Department of Oncology-Pathology, Karolinska Institute, 171 76 Stockholm, Sweden

Tóm tắt

Ionizing radiation causes DNA damage and consequent apoptosis, mainly due to the production of hydroxyl radicals (HO•) that follows radiolytic splitting of water. However, superoxide (O2•−) and H2O2 also form and induce oxidative stress with resulting LMP (lysosomal membrane permeabilization) arising from iron-catalysed oxidative events. The latter will contribute significantly to radiation-induced cell death and its degree largely depends on the quantities of lysosomal redox-active iron present as a consequence of autophagy and endocytosis of iron-rich compounds. Therefore radiation sensitivity might be depressed by lysosome-targeted iron chelators. In the present study, we have shown that cells in culture are significantly protected from ionizing radiation damage if initially exposed to the lipophilic iron chelator SIH (salicylaldehyde isonicotinoyl hydrazone), and that this effect is based on SIH-dependent lysosomal stabilization against oxidative stress. According to its dose-response-modifying effect, SIH is a most powerful radioprotector and a promising candidate for clinical application, mainly to reduce the radiation sensitivity of normal tissue. We propose, as an example, that inhalation of SIH before each irradiation session by patients undergoing treatment for lung malignancies would protect normally aerated lung tissue against life-threatening pulmonary fibrosis, whereas the sensitivity of malignant lung tumours, which usually are non-aerated, will not be affected by inhaled SIH.

Từ khóa


Tài liệu tham khảo

Arner, 2006, The thioredoxin system in cancer, Semin. Cancer Biol., 16, 420, 10.1016/j.semcancer.2006.10.009

Kinnula, 2004, Antioxidant enzymes and redox regulating thiol proteins in malignancies of human lung, FEBS Lett., 569, 1, 10.1016/j.febslet.2004.05.045

Cunnea, 2007, Increased expression of specific thioredoxin family proteins: a pilot immunohistochemical study on human hepatocellular carcinoma, Int. J. Immunopathol. Pharmacol., 20, 17, 10.1177/039463200702000103

Fernandes, 2009, Expression profiles of thioredoxin family proteins in human lung cancer tissue: correlation with proliferation and differentiation, Histopathology, 55, 313, 10.1111/j.1365-2559.2009.03381.x

Soini, 2001, Widespread expression of thioredoxin and thioredoxin reductase in non-small cell lung carcinoma, Clin. Cancer Res., 7, 1750

Roots, 1975, Estimation of life times and diffusion distances of radicals involved in X-ray-induced DNA strand breaks of killing of mammalian cells, Radiat. Res., 64, 306, 10.2307/3574267

Persson, 2005, Radiation-induced cell death: importance of lysosomal destabilization, Biochem. J., 389, 877, 10.1042/BJ20050271

Kurz, 2010, Redox activity within the lysosomal compartment: implications for aging and apoptosis, Antioxid. Redox Signaling, 13, 511, 10.1089/ars.2009.3005

Kurz, 2008, Lysosomes in iron metabolism, ageing and apoptosis, Histochem. Cell Biol., 129, 389, 10.1007/s00418-008-0394-y

Kurz, 2008, Lysosomes and oxidative stress in aging and apoptosis, Biochim. Biophys. Acta, 1780, 1291, 10.1016/j.bbagen.2008.01.009

Parkin, 2005, Global cancer statistics, 2002, CA Cancer J. Clin., 55, 74, 10.3322/canjclin.55.2.74

Beinert, 1999, Oxidant-induced lung injury in anticancer therapy, Eur. J. Med. Res., 4, 43

Andreassen, 2003, Chemical radioprotection: a critical review of amifostine as a cytoprotector in radiotherapy, Semin. Radiat. Oncol., 13, 62, 10.1053/srao.2003.50006

Werner-Wasik, 2005, Amifostine in chemoradiation therapy for non-small cell lung cancer: review of experience and design of a phase II trial assessing subcutaneous and intravenous bolus administration, Semin. Oncol., 32, S105, 10.1053/j.seminoncol.2005.03.018

Yu, 2003, The radioprotective agent, amifostine, suppresses the reactivity of intralysosomal iron, Redox Rep., 8, 347, 10.1179/135100003225003384

Kurz, 2006, Intralysosomal iron chelation protects against oxidative stress-induced cellular damage, FEBS J., 273, 3106, 10.1111/j.1742-4658.2006.05321.x

Abok, 1984, Dimethylsulfoxide increases the survival and lysosomal stability of mouse peritoneal macrophages exposed to low-LET ionizing radiation and/or ionic iron in culture, Virchows Arch. B Cell. Pathol. Incl. Mol. Pathol., 46, 307, 10.1007/BF02890319

Puck, 1956, Action of X-rays on mammalian cells, J. Exp. Med., 103, 653, 10.1084/jem.103.5.653

Sinclair, 1966, The shape of radiation survival curves of mammalian cells cultured in vitro, Biophysical Aspects of Radiation Quality, Technical Report Series No. 58, 21

Curtis, 1976, The OER of mixed high- and low-LET radiation, Radiat. Res., 65, 566, 10.2307/3574388

Zdolsek, 1993, H2O2-mediated damage to lysosomal membranes of J-774 cells, Free Radical Res. Commun., 18, 71, 10.3109/10715769309147344

Bergh, 1985, Establishment and characterization of cell lines from human small cell and large cell carcinomas of the lung, Acta Pathol. Microbiol. Immunol. Scand. A, 93, 133

Cedervall, 1994, Less initial rejoining of X-ray-induced DNA double-strand breaks in cells of a small cell (U-1285) compared to a large cell (U-1810) lung carcinoma cell line, Radiat. Res., 139, 34, 10.2307/3578729

Brodin, 1995, Increased radioresistance of an in vitro transformed human small cell lung cancer cell line, Lung Cancer, 12, 183, 10.1016/0169-5002(95)00444-6

Halliwell, 1999, The chemistry of free radicals and other related “reactive species”, Free Radicals in Biology and Medicine, 36

Mellstrom, 1987, Expression of c-src in cultured human neuroblastoma and small-cell lung carcinoma cell lines correlates with neurocrine differentiation, Mol. Cell. Biol., 7, 4178

Brunk, 1995, Lethal hydrogen-peroxide toxicity involves lysosomal iron-catalyzed reactions with membrane damage, Redox Rep., 1, 267, 10.1080/13510002.1995.11746997

Persson, 2003, Prevention of oxidant-induced cell death by lysosomotropic iron chelators, Free Radical Biol. Med., 34, 1295, 10.1016/S0891-5849(03)00106-0

Yu, 2003, Intralysosomal iron: a major determinant of oxidant-induced cell death, Free Radical Biol. Med., 34, 1243, 10.1016/S0891-5849(03)00109-6

Zdolsek, 1993, Visualization of iron in cultured macrophages: a cytochemical light and electron microscopic study using autometallography, Free Radical Biol. Med., 15, 1, 10.1016/0891-5849(93)90120-J

Warburg, 1962, New Methods of Cell Physiology Applied to Cancer, Photosynthesis, and Mechanism of X-Ray Action

Doulias, 2003, Endosomal and lysosomal effects of desferrioxamine: protection of HeLa cells from hydrogen peroxide-induced DNA damage and induction of cell-cycle arrest, Free Radical Biol. Med., 35, 719, 10.1016/S0891-5849(03)00396-4

Kurz, 2004, Relocalized redox-active lysosomal iron is an important mediator of oxidative-stress-induced DNA damage, Biochem. J., 378, 1039, 10.1042/bj20031029

Tenopoulou, 2005, Role of compartmentalized redox-active iron in hydrogen peroxide-induced DNA damage and apoptosis, Biochem. J., 387, 703, 10.1042/BJ20041650

Schafer, 2000, Acidic pH amplifies iron-mediated lipid peroxidation in cells, Free Radical Biol. Med., 28, 1175, 10.1016/S0891-5849(00)00319-1

Nilsson, 1997, Lysosomal heterogeneity between and within cells with respect to resistance against oxidative stress, Histochem. J., 29, 857, 10.1023/A:1026441907803

Terman, 2010, Mitochondrial turnover and aging of long-lived postmitotic cells: the mitochondrial–lysosomal axis theory of aging, Antioxid. Redox. Signaling, 12, 503, 10.1089/ars.2009.2598

Li, 2000, Induction of cell death by the lysosomotropic detergent MSDH, FEBS Lett., 470, 35, 10.1016/S0014-5793(00)01286-2

Cable, 1999, Cellular uptake and release of two contrasting iron chelators, J. Pharm. Pharmacol., 51, 131, 10.1211/0022357991772231

Lloyd, 1991, Evidence that desferrioxamine cannot enter cells by passive diffusion, Biochem. Pharmacol., 41, 1361, 10.1016/0006-2952(91)90109-I

Grdina, 1989, Radiation protectors: the unexpected benefits, Drug Metab. Rev., 20, 13, 10.3109/03602538908994143

Held, 1985, Interactions of radioprotectors and oxygen in cultured mammalian cells. I. Dithiothreitol effects on radiation-induced cell killing, Radiat. Res., 101, 424, 10.2307/3576501

Murray, 1988, Radioprotective action of aminothiols in vitro and in vivo: comparison between effects on DNA damage and cell survival, Pharmacol. Ther., 39, 151, 10.1016/0163-7258(88)90055-1

Patt, 1949, Cysteine protection against X irradiation, Science, 110, 213, 10.1126/science.110.2852.213

Vos, 1962, Protection of tissue culture cells against ionizing radiation. I. The effect of biological amines, disulphide compounds and thiols, Int. J. Radiat. Biol., 5, 543

Weiss, 1997, Pharmacologic approaches to protection against radiation-induced lethality and other damage, Environ. Health Perspect., 105, 1473

Weiss, 2003, Protection against ionizing radiation by antioxidant nutrients and phytochemicals, Toxicology, 189, 1, 10.1016/S0300-483X(03)00149-5